Exemed Pharmaceuticals gets CDSCO panel Nod To Manufacture, Market Antidiabetic Drug Imeglimin HCl SR Tablets Dr. Divya Colin26 Nov 2023 5:45 PM ISTNew Delhi: Based on the bioequivalence study report and Phase III clinical trial report of the antidiabetic drug Imeglimin hydrochloride presented by...
Imeglimin lowers CVD risk by improving postprandial flow-mediated dilation among diabetes patients Dr Kartikeya Kohli6 Feb 2023 10:45 AM ISTCardiovascular disease (CVD) is the major cause of mortality in type 2 diabetes and high blood sugar, dyslipidemia, and hypertension are risk factors...
Imeglimin, a potential new treatment option as add-on to insulin therapy in type 2 diabetes: TIMES 3 trial Medha Baranwal15 Feb 2022 9:15 AM ISTFrance: Recent data from the TIMES-3 trial showed that imeglimin when used as an add-on agent to insulin was effective in reducing blood sugar levels...
CDSCO panel rejects Synokem Pharma proposal for oral antidiabetic drug Imeglimin Medical Dialogues Team19 Nov 2021 8:14 PM ISTNew Delhi: Rejecting the drug major Synokem Pharma's proposal for oral anti-diabetic medication Imeglimin 500mg and 1000mg Tab, the Subject Expert...
Novel drug Imeglimin safe option for controlling blood sugar in Diabetes: Study Medha Baranwal7 April 2021 10:44 AM ISTJapan: Patients with type 2 diabetes (T2D) who received twice-daily 100mg of imeglimin monotherapy showed significant improvements in blood sugar...
